Aura Biosciences, Inc. (AURA)
6.47
+0.12
(+1.89%)
USD |
NASDAQ |
Dec 10, 16:00
6.475
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Free Cash Flow: -88.80M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| 4D Molecular Therapeutics, Inc. | -185.05M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
| Theriva Biologics, Inc. | -18.51M |
| Oragenics, Inc. | -8.429M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.14M |
| Cash from Investing (Quarterly) | -44.02M |
| Cash from Financing (Quarterly) | 4.363M |
| Free Cash Flow Per Share (Quarterly) | -0.3062 |
| Free Cash Flow to Equity (Quarterly) | -19.83M |
| Free Cash Flow to Firm (Quarterly) | -20.19M |
| Free Cash Flow Yield | -24.51% |